Furthermore, CD133+ glioblastoma stem cells exhibited the ability to recruit hUCBMSCs, which can further promote tumor growth in vivo, via exosomes containing MCP-1/CCL2 and SDF-1/CXCL12 [160]. This evidence concerns the gene CCL2 and glioblastoma.